Medeon Biodesign held an investor conference on the 12th, chaired by Chairman Dr. Zhang You-De. Dr. Zhang provided updates on the development progress of two innovative medical devices and the status of the company’s CDMO (Contract Development and Manufacturing Organization) services. He also addressed investor questions, highlighting the advantages of their innovative medical devices over similar market products and discussing the current cooperation with Terumo. Dr. Zhang evaluated the subsequent $20 million milestone payment following the sale of Cross Seal to Terumo and mentioned that a new timeline for milestone recognition is being developed. He acknowledged that some adjustments are to be expected in the negotiations, but assured that the Medeon Biodesign team is "diligently preparing."
Read more
